Rising Smoking Prevalence Driving COPD Drugs Market Growth

ha aggiunto una foto Altre informazioni

2026-05-13 12:44:54 -

The Chronic Obstructive Pulmonary Disease (COPD) Drugs Market is witnessing strong expansion driven by rising respiratory disease prevalence, growing aging populations, and significant advancements in inhalation therapies and biologics. COPD, a progressive lung disease including chronic bronchitis and emphysema, continues to be one of the leading causes of mortality worldwide. As healthcare...

0 Commenti 0 condivisioni 50 Views 0 Anteprima